コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 modulation, including the down-regulation of connective tissue growth factor.
2 carcinoid tumors, including neurotensin and connective tissue growth factor.
3 ondin, plasminogen activator inhibitor 1, or connective tissue growth factor.
4 can be rescued by the addition of exogenous connective tissue growth factor.
5 expression of extracellular matrix genes and connective tissue growth factor.
6 members, collagen-interacting proteins, and connective tissue growth factor.
7 alization of TAZ and increased expression of connective tissue growth factor.
8 ed the angiogenesis-promoting gene Cyr61 and connective tissue growth factor.
9 KLF5 synergistically enhances expression of connective tissue growth factor.
10 xpression of several key genes, particularly connective tissue growth factor.
11 pregulation of type II TGF-beta receptor and connective tissue growth factor.
12 ro-fibrotic marker gene expression including connective tissue growth factor.
13 d cytoskeletal reorganization to TGF-beta or connective tissue growth factor.
14 61, nephroblastoma overexpressed) family of connective tissue growth factors.
15 the transcription of a second growth factor, connective tissue growth factor 1 (CTGF), which could me
16 d 21-fold increase, respectively, P < 0.05), connective tissue growth factor (2.5-fold increase, P <
19 cked LATS1 from inhibiting the expression of connective tissue growth factor, a YAP-regulated gene.
20 minantly by inhibiting PDGF-, TGF-beta-, and connective tissue growth factor-activated MAPK and JNK s
21 , green fluorescent protein (Ad CMV.GFP), or connective tissue growth factor (AdCMV.CTGF) were inject
22 as either transforming growth factor beta or connective tissue growth factor alone produce only a tra
23 oalveolar lavage fluid and assessed for KGF, connective tissue growth factor, alpha-smooth muscle act
26 esis, were increased and expression level of connective tissue growth factor, an inhibitor of adipoge
27 rization induced the autocrine growth factor connective tissue growth factor and activated ERK surviv
29 expression of two TEAD-dependent genes, the connective tissue growth factor and amphiregulin genes.
30 hat encodes growth regulators, including the connective tissue growth factor and an avian proto-oncop
31 duced upregulation of the fibrogenic protein connective tissue growth factor and collagen III in vitr
32 ury as well as decreased renal expression of connective tissue growth factor and collagens I and IV.
37 sts, in contrast, promoted a SMAD3-dependent connective tissue growth factor and plasminogen activato
38 thelial cell-cycle arrest via SMAD3-mediated connective tissue growth factor and plasminogen activato
39 of growth regulators that includes the human connective tissue growth factor and the chicken protoonc
40 mRNA levels of profibrotic genes, including connective tissue growth factor and tissue inhibitor of
41 produce only a transient fibrotic response, connective tissue growth factor and transforming growth
42 d in the renal expression of growth factors (connective tissue growth factor and vascular endothelial
44 or-beta, endothelin-1, angiotensin II, CCN2 (connective tissue growth factor), and platelet-derived g
45 up-regulated, including COL1A1, COL1A2, and connective tissue growth factor, and 206 genes were down
46 ally, dabigatran etexilate reduced collagen, connective tissue growth factor, and alpha-smooth muscle
47 SCAI interfered with TGF-beta1-induced SMA, connective tissue growth factor, and calponin protein ex
48 iators, transforming growth factor-beta1 and connective tissue growth factor, and diminished myofibro
53 itor-1, parathyroid hormone-related peptide, connective tissue growth factor, and matrix metallopepti
54 , including transforming growth factor-beta, connective tissue growth factor, and matrix metalloprote
55 genic and proinflammatory factors (TGF-beta, connective tissue growth factor, and monocyte chemoattra
56 on (>95%) and subsequent PAI-1, fibronectin, connective tissue growth factor, and p21 expression in h
57 genetic protein 7, hepatocyte growth factor, connective tissue growth factor, and pirfenidone have sh
59 pression of transforming growth factor-beta, connective tissue growth factor, and type III collagen.
60 pression of transforming growth factor-beta, connective tissue growth factor, and vascular endothelia
61 ctor alpha, transforming growth factor beta, connective tissue growth factor, and vascular endothelia
62 anti-apoptotic protein Bcl-xL, beta-catenin, connective tissue growth factor, and vascular endothelia
63 rming growth factor-beta, interleukin-4, and connective tissue growth factor are implicated in induci
65 mbined elimination of TGF-beta signaling and connective tissue growth factor as a potential therapeut
66 sm of type I collagen production and suggest connective tissue growth factor as its potent mediator.
67 entire coding region of human CTGF (encoding connective tissue growth factor) as a probe and by 5'RAC
68 ed increased expression of both collagen and connective tissue growth factor, as well as nuclear enri
69 s recent information regarding insights into connective tissue growth factor biology and, using scler
71 e myosins, NotchR and Wnt pathway genes, and connective tissue growth factor by Pofut1 in skeletal mu
73 if hypoxia-inducible factor (HIF)-1alpha and connective tissue growth factor (CCN2) form a regulatory
77 at activated PSCs of the fibrogenic protein, connective tissue growth factor (CCN2), and to determine
78 ecreted matricellular proteins that includes connective tissue growth factor (CCN2), NOV (CCN3), WISP
83 pproach and demonstrated a broad affinity of connective tissue growth factor (CCN2/CTGF) to C-termina
84 ding fibronectin, alpha-smooth muscle actin, connective tissue growth factor, collagen I, and TGF-bet
85 d the expression of the ECM-associated genes connective tissue growth factor, collagen-alpha1[Iota],
87 cytosol, increase expression of YAP and TAZ connective tissue growth factor (CTGF) and Cyr61 target
90 is study, we characterized the expression of connective tissue growth factor (CTGF) and transforming
92 acellular matrix (ECM) complex consisting of connective tissue growth factor (CTGF) and vascular endo
94 teine-rich angiogenic protein 61 (Cyr61) and connective tissue growth factor (CTGF) are structurally
97 Wnt3A and osteogenic BMPs, and we identified connective tissue growth factor (CTGF) as a potential ta
102 TGF-beta1 (TGFB1), Collagen1alpha1, and connective tissue growth factor (CTGF) gene expression w
103 thways controlling the TGF-beta induction of connective tissue growth factor (CTGF) gene expression.
105 r, transforming growth factor (TGF)-beta and connective tissue growth factor (CTGF) genes are co-ordi
107 ssesses for the presence and localization of connective tissue growth factor (CTGF) in drug-induced g
108 the expression of collagen, fibronectin, and connective tissue growth factor (CTGF) in normal and SSc
109 wth factor (HGF) down-regulates collagen and connective tissue growth factor (CTGF) in scleroderma (s
111 body of evidence suggests the involvement of connective tissue growth factor (CTGF) in the developmen
143 rowth factor/Cyr61/NOV (CCN) family members, connective tissue growth factor (CTGF) may be particular
144 receptor by des-Arg(10)-kallidin stabilized connective tissue growth factor (CTGF) mRNA, stimulated
147 e aim of this study was to determine whether connective tissue growth factor (CTGF) regulates the pro
151 rential cDNA microarray analyses showed that connective tissue growth factor (CTGF) was expressed at
152 th-factor beta axis was enhanced in POH, and connective tissue growth factor (CTGF) was overexpressed
155 genome-wide array technology, we found that connective tissue growth factor (CTGF), a gene product d
157 Arg(10)-kallidin stimulate the expression of connective tissue growth factor (CTGF), a matrix signali
160 1-derived peptide sequence and its effect on connective tissue growth factor (CTGF), a protein involv
161 data about a structure function analysis of connective tissue growth factor (CTGF), a prototypic mem
162 ubular injury, fibrosis, collagen synthesis, connective tissue growth factor (CTGF), and alpha-smooth
163 cysteine-rich angiogenic inducer 61 (CYR61), connective tissue growth factor (CTGF), and ankyrin repe
165 EGF), transforming growth factor (TGF)-beta, connective tissue growth factor (CTGF), and collagens IV
166 in-1, collagen I, alpha-smooth muscle actin, connective tissue growth factor (CTGF), and plasminogen
167 shown that expression of CCN2, also known as connective tissue growth factor (CTGF), correlates posit
168 thelial cells induced these cells to express connective tissue growth factor (CTGF), driving fibrobla
169 TGF-beta), TGF-beta receptor 1 (TGF-betaR1), connective tissue growth factor (CTGF), E-cadherin, SRY-
170 ownregulation of fibrosis markers, including connective tissue growth factor (CTGF), fibronectin, and
172 transforming growth factor beta (TGF-beta), connective tissue growth factor (CTGF), IL-4, IL-13, MCP
173 n and stimulators of collagen synthesis, eg, connective tissue growth factor (CTGF), in patients with
176 ng this process, we investigated the role of connective tissue growth factor (CTGF), one of the candi
177 F-1), tumor growth factor beta1 (TGF-beta1), connective tissue growth factor (CTGF), procollagen I ca
179 ranscription and/or protein levels of SPARC, connective tissue growth factor (CTGF), type I collagen,
180 , some TGFbeta-regulated proteins, including connective tissue growth factor (CTGF), were basally upr
181 the profibrotic factors tenascin C (TNC) and connective tissue growth factor (CTGF), whereas forced e
182 wnstream effects of TGF-beta are mediated by connective tissue growth factor (CTGF), which is up-regu
183 es in human breast carcinomas, we quantified connective tissue growth factor (CTGF), WISP-1, CYR61, a
190 l fibrosis, particularly CCN2 [also known as connective tissue growth factor (CTGF)], markers of epit
193 transforming growth factor-beta (TGF-beta), connective tissue growth factor (CTGF, CCN2), and ED-A f
195 ere statistically significant in four genes: connective tissue growth factor (Ctgf, P = 0.04), tenasc
196 d that there was a 7.5-fold up-regulation of connective tissue growth factor (CTGF/CCN2) expression i
203 Several lines of evidence indicate that connective tissue growth factor (CTGF/CCN2) stimulates c
205 .CT signaling that induces the expression of connective tissue growth factor (CTGF/CCN2), a potent me
212 xpression of the classical Hippo target CCN2/connective-tissue growth factor (CTGF), as well as ancho
213 overexpressed gene) is a member of the CCN (connective tissue growth factor [CTGF], Cyr61/Cef10, NOV
214 CCN1 and the homologous family members CCN2 (connective tissue growth factor, CTGF) or CCN3 (NOV) but
215 d protein 1 (WISP-1) is a member of the CCN (connective tissue growth factor, Cyr61, NOV) family of g
216 d protein 1 (WISP-1) is a member of the CCN (connective tissue growth factor, Cyr61, NOV) family of g
217 regulator family called CCN, which includes connective-tissue growth factor, CYR61, CEF10 (v-src ind
218 ta on fibroblast properties induction of the connective tissue growth factor/Cyr61/NOV (CCN) family m
219 fibrosis as assessed by decreased levels of connective tissue growth factor, cysteine-rich 61, colla
220 secreted protein 3) is a member of the CCN (connective tissue growth factor, cysteine-rich 61, nephr
221 ain, secreted protein, whose paralogous CCN (connective tissue growth factor/cysteine-rich protein 61
222 rogenitor cells were selectively enriched by connective tissue growth factor delivery (CTGF delivery)
223 tically decreased (by more than 2-fold) were connective tissue growth factor, endothelin-1, monocyte
226 vels, which coincided with (1) a decrease in connective tissue growth factor expression, (2) a reduct
229 rs such as platelet-derived growth factor-c, connective tissue growth factor, fibroblast growth facto
230 f fibrosis (transforming growth factor-beta, connective tissue growth factor, fibronectin, collagen-1
231 , HSPA8, HSPE1 and AXIN1, BRCA1, CD14, CTGF (connective tissue growth factor), GABRE (gamma-aminobuty
232 /endothelial cell adhesion gene (Thbs4), the connective tissue growth factor gene (Ctgf), and the sel
233 tor beta/Smad responsiveness elements in the connective tissue growth factor gene promoter, in human
234 transcriptional responses of the endogenous connective tissue growth factor gene to different physio
236 endothelial growth factor, thrombospondin 1, connective tissue growth factor, hepatocyte growth facto
238 phosphorylation and reduced transcription of connective tissue growth factor in an AIP4-dependent man
240 ncluding transforming growth factor-beta and connective tissue growth factor, in muscles of periodate
241 bulin, vascular endothelial growth factor A, connective tissue growth factor, insulin-like growth fac
247 ransforming growth factor-beta1 (TGF-beta1), connective tissue growth factor, matrix metalloproteinas
248 sing scleroderma as a model system, the part connective tissue growth factor might play in fibrotic d
250 inimal erythema dose, UVB/A2 source) reduced connective tissue growth factor mRNA expression througho
253 se chain reaction revealed that the level of connective tissue growth factor mRNA in the epidermis an
254 Previous irradiation-enhanced induction of connective tissue growth factor mRNA in wild-type, but n
256 sforming growth factor beta1 rapidly induced connective tissue growth factor mRNA levels (5-fold with
258 In situ hybridization demonstrated that connective tissue growth factor mRNA was expressed in ke
260 xpression of fibronectin, procollagen I, and connective tissue growth factor mRNA, MMP-2 activity, an
261 the upregulation of cutaneous TGF-beta1 and connective tissue growth factor mRNAs and type I collage
262 that cysteine-rich protein 61 (CYR61)/CYR61 connective tissue growth factor nephroblastoma overexpre
263 ed family of secreted proteins that includes connective tissue growth factor, nephroblastoma overexpr
264 his gene is a member of the cysteine-rich 61/connective tissue growth factor/nephroblastoma-overexpre
265 overexpressed (Nov), a member of the Cyr 61, connective tissue growth factor, Nov (CCN) family of pro
266 otein of the CCN family, which also includes connective tissue growth factor, Nov, WISP-1, WISP-2, an
267 uid from patients with ALI/ARDS induced more connective tissue growth factor (p < 0.05), collagen 1 (
268 with senescence and/or apoptosis (TGF-beta1, connective tissue growth factor, p53, alpha-synuclein, a
272 on of reporter genes for the p21, cdc25, and connective tissue growth factor promoters and of a repor
273 utes to the phenotype of scleroderma in that connective tissue growth factor promotes matrix depositi
275 agonists of transforming growth factor-beta, connective tissue growth factor, several tyrosine kinase
276 including plasminogen activator inhibitor-1, connective tissue growth factor, Smad3, Smad4, and Smad7
278 release of cytokines and growth factors like connective tissue growth factor that induce an active an
279 down-regulation of the steady-state level of connective tissue growth factor that induces collagen ty
280 -regulated the expression of Cyr61 and CTGF (connective tissue growth factor), the genes that encode
281 nd fibrogenic cytokines such as TGFbeta2 and connective tissue growth factor.This inhibitory effect o
283 ents targeting specific cytokines, including connective tissue growth factor, transforming growth fac
288 broblasts, whereas its human ortholog, CTGF (connective tissue growth factor), was identified as a mi
289 decorin, important for the interaction with connective tissue growth factor, was detected predominan
290 ogen activator inhibitor-1, fibronectin, and connective tissue growth factor, was suppressed by metfo
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。